| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |